Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134,020 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.
Xu H, Van der Jeught K, Zhou Z, Zhang L, Yu T, Sun Y, Li Y, Wan C, So KM, Liu D, Frieden M, Fang Y, Mosley AL, He X, Zhang X, Sandusky GE, Liu Y, Meroueh SO, Zhang C, Wijeratne AB, Huang C, Ji G, Lu X. Xu H, et al. Among authors: zhang l, zhang c, zhang x. J Clin Invest. 2021 May 17;131(10):e146832. doi: 10.1172/JCI146832. J Clin Invest. 2021. PMID: 33830945 Free PMC article.
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II.
Li Y, Liu Y, Xu H, Jiang G, Van der Jeught K, Fang Y, Zhou Z, Zhang L, Frieden M, Wang L, Luo Z, Radovich M, Schneider BP, Deng Y, Liu Y, Huang K, He B, Wang J, He X, Zhang X, Ji G, Lu X. Li Y, et al. Among authors: zhang l, zhang x. Nat Commun. 2018 Oct 22;9(1):4394. doi: 10.1038/s41467-018-06811-z. Nat Commun. 2018. PMID: 30349055 Free PMC article.
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer.
Liu Y, Xu J, Choi HH, Han C, Fang Y, Li Y, Van der Jeught K, Xu H, Zhang L, Frieden M, Wang L, Eyvani H, Sun Y, Zhao G, Zhang Y, Liu S, Wan J, Huang C, Ji G, Lu X, He X, Zhang X. Liu Y, et al. Among authors: zhang l, zhang x, zhang y. Nat Commun. 2018 Nov 9;9(1):4718. doi: 10.1038/s41467-018-07264-0. Nat Commun. 2018. PMID: 30413718 Free PMC article.
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity.
Zhou Z, Van der Jeught K, Fang Y, Yu T, Li Y, Ao Z, Liu S, Zhang L, Yang Y, Eyvani H, Cox ML, Wang X, He X, Ji G, Schneider BP, Guo F, Wan J, Zhang X, Lu X. Zhou Z, et al. Among authors: zhang l, zhang x. Nat Biomed Eng. 2021 Nov;5(11):1320-1335. doi: 10.1038/s41551-021-00805-x. Epub 2021 Nov 1. Nat Biomed Eng. 2021. PMID: 34725507 Free PMC article.
Targeting SMARCAL1 as a novel strategy for cancer therapy.
Zhang L, Fan S, Liu H, Huang C. Zhang L, et al. Biochem Biophys Res Commun. 2012 Oct 19;427(2):232-5. doi: 10.1016/j.bbrc.2012.09.060. Epub 2012 Sep 17. Biochem Biophys Res Commun. 2012. PMID: 22995303 Review.
134,020 results
You have reached the last available page of results. Please see the User Guide for more information.